Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein
- 2 July 2004
- Vol. 326 (1) , 140-149
- https://doi.org/10.1016/j.virol.2004.05.017
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Assessment of Immunoreactive Synthetic Peptides from the Structural Proteins of Severe Acute Respiratory Syndrome CoronavirusClinical Chemistry, 2003
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 LineagePublished by Elsevier ,2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Foamy Virus Envelope Glycoprotein-Mediated Entry Involves a pH-Dependent Fusion ProcessJournal of Virology, 2003
- Development of a Safe and Rapid Neutralization Assay Using Murine Leukemia Virus Pseudotyped with HIV Type 1 Envelope Glycoprotein Lacking the Cytoplasmic DomainAIDS Research and Human Retroviruses, 2001
- Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variantJournal of General Virology, 1993
- Coronavirus IBV-induced membrane fusion occurs at near-neutral pHArchiv für die gesamte Virusforschung, 1992
- Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoproteinVirus Research, 1991
- Initial events in bovine coronavirus infection: analysis through immunogold probes and lysosomotropic inhibitorsArchiv für die gesamte Virusforschung, 1990